Fandy TE - Search Results

1

Smac/DIABLO enhances the therapeutic potential of chemotherapeutic drugs and irradiation, and sensitizes TRAIL-resistant breast cancer cells.

Fandy TE, Shankar S, Srivastava RK. Fandy TE, et al. Mol Cancer. 2008 Jun 30;7:60. doi: 10.1186/1476-4598-7-60. Mol Cancer. 2008. PMID: 18590557 Free PMC article.

2

Epigenetic targets in human neoplasms.

Fandy TE, Gore SD. Fandy TE, et al. Epigenomics. 2010 Apr;2(2):221-32. doi: 10.2217/epi.10.1. Epigenomics. 2010. PMID: 22121872 Review.

3

Development of DNA methyltransferase inhibitors for the treatment of neoplastic diseases.

Fandy TE. Fandy TE. Curr Med Chem. 2009;16(17):2075-85. doi: 10.2174/092986709788612738. Curr Med Chem. 2009. PMID: 19519382 Review.

4

DNA demethylating agents and histone deacetylase inhibitors in hematologic malignancies.

Fandy TE, Carraway H, Gore SD. Fandy TE, et al. Cancer J. 2007 Jan-Feb;13(1):40-8. doi: 10.1097/PPO.0b013e31803c7359. Cancer J. 2007. PMID: 17464245 Review.

5

Curcumin and dimethoxycurcumin induced epigenetic changes in leukemia cells.

Hassan HE, Carlson S, Abdallah I, Buttolph T, Glass KC, Fandy TE. Hassan HE, et al. Among authors: fandy te. Pharm Res. 2015 Mar;32(3):863-75. doi: 10.1007/s11095-014-1502-4. Epub 2014 Sep 4. Pharm Res. 2015. PMID: 25186441

6

Decitabine induces delayed reactive oxygen species (ROS) accumulation in leukemia cells and induces the expression of ROS generating enzymes.

Fandy TE, Jiemjit A, Thakar M, Rhoden P, Suarez L, Gore SD. Fandy TE, et al. Clin Cancer Res. 2014 Mar 1;20(5):1249-58. doi: 10.1158/1078-0432.CCR-13-1453. Epub 2014 Jan 14. Clin Cancer Res. 2014. PMID: 24423613 Free PMC article.

7

Flavopiridol synergizes TRAIL cytotoxicity by downregulation of FLIPL.

Fandy TE, Ross DD, Gore SD, Srivastava RK. Fandy TE, et al. Cancer Chemother Pharmacol. 2007 Aug;60(3):313-9. doi: 10.1007/s00280-006-0381-8. Epub 2006 Dec 23. Cancer Chemother Pharmacol. 2007. PMID: 17187253

8

IMP dehydrogenase inhibitor mycophenolate mofetil induces caspase-dependent apoptosis and cell cycle inhibition in multiple myeloma cells.

Takebe N, Cheng X, Fandy TE, Srivastava RK, Wu S, Shankar S, Bauer K, Shaughnessy J, Tricot G. Takebe N, et al. Among authors: fandy te. Mol Cancer Ther. 2006 Feb;5(2):457-66. doi: 10.1158/1535-7163.MCT-05-0340. Mol Cancer Ther. 2006. PMID: 16505121

9

Trichostatin A sensitizes TRAIL-resistant myeloma cells by downregulation of the antiapoptotic Bcl-2 proteins.

Fandy TE, Srivastava RK. Fandy TE, et al. Cancer Chemother Pharmacol. 2006 Oct;58(4):471-7. doi: 10.1007/s00280-005-0184-3. Epub 2006 Jan 25. Cancer Chemother Pharmacol. 2006. PMID: 16435155

10

Interactive effects of HDAC inhibitors and TRAIL on apoptosis are associated with changes in mitochondrial functions and expressions of cell cycle regulatory genes in multiple myeloma.

Fandy TE, Shankar S, Ross DD, Sausville E, Srivastava RK. Fandy TE, et al. Neoplasia. 2005 Jul;7(7):646-57. doi: 10.1593/neo.04655. Neoplasia. 2005. PMID: 16026644 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results